Stay updated with breaking news from Algert Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cerus (NASDAQ:CERS – Free Report) had its price objective raised by Cantor Fitzgerald from $3.00 to $4.00 in a research report sent to investors on Friday morning, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. A number of other analysts have also commented on CERS. Stephens reiterated an equal weight […]
JPMorgan Chase & Co. lowered shares of Driven Brands (NASDAQ:DRVN – Free Report) from an overweight rating to a neutral rating in a research report report published on Friday morning, Marketbeat.com reports. The firm currently has $12.50 price objective on the stock, down from their previous price objective of $18.00. A number of other analysts […]
Axonics, Inc. (NASDAQ:AXNX – Get Free Report) has been given an average rating of “Hold” by the thirteen ratings firms that are presently covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year price target among brokers […]
Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report issued on Friday morning, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, Stifel Nicolaus assumed coverage on shares of Phathom Pharmaceuticals in a research report on Friday. They set […]
StockNews.com cut shares of MiMedx Group (NASDAQ:MDXG – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Friday morning. A number of other equities research analysts also recently weighed in on MDXG. Lake Street Capital started coverage on MiMedx Group in a research note on Thursday, […]